Navigation Links
ASP Launches STERRAD(R) Sterility Guide - Eliminating Paperwork and Ensuring Compliance
Date:11/3/2008

New Online Tool Informs Customers Which Instruments Can be Sterilized in

STERRAD(R) Systems with a Few Clicks of a Mouse

IRVINE, Calif., Nov. 3 /PRNewswire/ -- Advanced Sterilization Products (ASP), division of Ethicon Inc., is pleased to unveil a new global initiative that will support the needs of healthcare professionals who are faced with infection prevention concerns. The STERRAD(R) Sterility Guide, a first-of-its-kind online tool, is designed to help healthcare professionals around the world quickly, easily and accurately determine which instruments can be sterilized in STERRAD(R) Systems.

As more and more medical devices come to market and infection control standards are monitored by industry groups, there is an acute need to provide accurate and up-to-date guidance to hospital staff on which devices can be sterilized in STERRAD(R) Systems. To fulfill this unmet need and demonstrate its commitment to following the Association for the Advancement of Medical Instrumentation (AAMI) and Association of periOperative Registered Nurses (AORN) Standards and Recommended Practices, ASP took the lead and developed the STERRAD(R) Sterility Guide.

"I visit customers each week and I'm constantly surprised when I see the mounds of outdated paperwork and thick manuals they need to sift through in order to determine whether a device can be sterilized in a specific sterilizer," said Barbara Trattler, RN, MPA, CNOR, CNA, and Director of Clinical Education at ASP. "Now, with the STERRAD(R) Sterility Guide, STERRAD(R) System customers can simply visit the STERRAD(R) Web site at their convenience in order to receive a timely and accurate answer -- it's so easy and the results are current."

By following a few simple steps on the new, easy-to-use Web site, http://www.sterrad.com/sterilityguide, STERRAD(R) System customers can immediately obtain confirmation 24 hours a day, seven days a week as to whether a device can be sterilized in a STERRAD(R) System. All devices listed on the STERRAD(R) Sterility Guide have been approved for use in a STERRAD(R) System by the appropriate medical device manufacturer. And because ASP has partnered with medical device manufacturers around the world, new devices will be added on a regular basis.

Safety. Speed. Simplicity. 15 Years of STERRAD(R) System Innovation

STERRAD(R) Sterilization Systems have been on the market for 15 years and a market-leading 11,000 STERRAD(R) System units have been installed worldwide. The launch of the new STERRAD(R) Sterility Guide will enable customers to better utilize their STERRAD(R) System.

About ASP

Advanced Sterilization Products (ASP), division of Ethicon, Inc., a Johnson & Johnson company, has a long track record of designing and delivering innovative infection prevention solutions that dramatically raise the level of health and safety for those who matter most. Our pioneering technology, global distribution, and established leadership position enable us to simplify the process of buying and operating infection prevention products and services every day, for thousands of medical facilities around the world. This in turn enables our customers to focus on what they do best -- preventing infection and saving lives.

For Information Contact:

Scott Shadiow

Dorland Global

415-262-5206 (office)

sshadiow@dorland.com

Katie Sweet

Advanced Sterilization Products

949-789-3945 (office)

ksweet@its.jnj.com


'/>"/>
SOURCE Advanced Sterilization Products
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
2. UPMC Health Plan Launches New Personal Health Record
3. HealthInsuranceFinders.com Launches Video Contest for Young Directors
4. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
5. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
6. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
7. Mannatech Launches Phase One of New Sales and Training Tools
8. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
9. Actavis Launches Carvedilol Tablets in the U.S.
10. MedQuist Re-launches New, Improved Web Site
11. Elsevier launches new journal: Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one of the most ... touted to be the next revolution in our fight against this complex disease. One ... of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While a few ...
(Date:3/29/2017)... (PRWEB) , ... March 29, ... ... suburbs and South Hills of Pittsburgh now have easier access to the ... only by Allegheny Health Network (AHN). Orthopaedic surgeons at Forbes Hospital and ...
(Date:3/29/2017)... ... March 29, 2017 , ... The Wharton School of ... Julie Taffet Moelis, W’81, have made a $10 million gift to establish the ... that will provide a pathway to a Wharton MBA for highly-qualified Penn undergraduates whose ...
(Date:3/29/2017)... ... March 29, 2017 , ... VisualSP has helped over ... recently, the only option for on-premises installation of its Help System for SharePoint was ... install the system into the entire tenant. , The company recently released a ...
(Date:3/28/2017)... ... ... Tuesday, March 28, 2017, is the annual American Diabetes Association Alert Day, ... find out if they are at risk for developing Type 2 diabetes. In recognition ... by programming the LAX pylons the color red. Downtown’s U.S. Bank Tower Crown Lights ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)...  Glenmark Pharmaceuticals, a global pharmaceutical company, today ... fixed-dose combination of mometasone furoate (25 mcg) and ... nasal spray being studied for the treatment of ... recently completed Phase 3 trial assessing the efficacy ... mometasone, olopatadine or placebo. "We continue ...
(Date:3/29/2017)... , March 29, 2017  The Pharmaceutical Care Management ... new PhRMA report on patient out-of-pocket spending: ... and Medicaid Services (CMS), the average amount spent out-of-pocket ... of drug spending in 2016, down from 23% in ... pricing problem, not a coverage problem. Health plans don,t ...
(Date:3/29/2017)...  NuVasive, Inc. (NASDAQ: NUVA), a leading medical ... minimally disruptive, procedurally-integrated solutions, today announced U.S. Food ... CoRoent® Small Interbody™ System indicated for intervertebral body ... spine. This marks the first U.S. clearance for ... to four contiguous levels. Cervical radiculopathy ...
Breaking Medicine Technology: